Bioactivity improvement of poly(ε-caprolactone) membrane with the addition of nanofibrous bioactive glass

Acta Biomaterialia

Volumn 4, Issue 3, 2008, Pages 622-629

  Lee, Hae Hyoung ^a,c   Yu, Hye Sun ^a   Jang, Jun Hyeog ^b   Kim, Hae Won ^a,c  

^a Dankook University   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c BK21 Plus NBM Global Research Center for Regenerative Medicine   (South Korea)

Author keywords

Bioactivity; Glass nanofiber; Guided bone regeneration (GBR) model; Osteoblast responses; Poly( caprolactone)

Indexed keywords

BIOACTIVITY; BONE; MEMBRANES; NANOCOMPOSITES; NANOFIBERS; PHOSPHATASES; PHOSPHATE MINERALS;

BIOACTIVES; GLASS NANOFIBERS; GUIDED BONE REGENERATION; GUIDED BONE REGENERATION MODEL; NANO-COMPOSITE MEMBRANES; NANO-FIBROUS; OSTEOBLAST RESPONSE; POLY(Ε CAPROLACTONE); POLY(Ε-CAPROLACTONE); REGENERATION MODEL;

BIOACTIVE GLASS;

ALKALINE PHOSPHATASE BONE ISOENZYME; APATITE; GLASS FIBER; MINERAL; NANOFIBER; POLYCAPROLACTONE;

ANIMAL CELL; ARTICLE; BIODEGRADABILITY; BODY FLUID; BONE REGENERATION; CELL GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; INCUBATION TIME; MOUSE; NONHUMAN; OSTEOBLAST; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; SIMULATION; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY;

MURINAE;

EID: 41549135535     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2007.10.013     Document Type: Article

References (33)

1. Hench L.L. Bioceramics: from concept to clinic. J Am Ceram Soc 81 (1998) 1785
2. Hench L.L., and Polak J.M. Third-generation biomedical materials. Science 295 (2002) 1014
3. Dorozhkin S.V., and Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed 41 (2002) 3130
4. Wilson J., Yli-Urpo A., and Happonen R.P. Bioactive glasses: clinical applications. In: Hench L.L., and Wilson J. (Eds). An introduction to bioceramics (1993), World Scientific, Singapore 63
5. Kokubo T. Bioactive glass ceramics: properties and applications. Biomaterials 12 (1991) 155
6. Wool R. The science and engineering of polymer composite degradation. In: Scott G., and Gilead D. (Eds). Degradable polymers and applications (1995), Chapman & Hall, London 138
7. Kimura Y. Biodegradable polymers. In: Tsuruta T. (Ed). Biomedical applications of polymeric materials (1993), CRC Press, Boca Raton, FL 163
8. Barrows T. Degradable implant materials: a review of synthetic absorbable polymers and their applications. Clin Mater 1 (1986) 233-257
9. Kimura Y. Biodegradable polymers. In: Tsuruta T. (Ed). Biomedical applications of polymeric materials (1993), CRC Press, Boca Raton, FL 163-189
10. Taylor M.S., Daniels A.U., Andriano K.P., and Heller J. Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. J Appl Biomater 5 (1994) 151-157
11. Kim H.W., Knowles J.C., and Kim H.E. Development of hydroxyapatite bone scaffold for controlled drug release via poly(ε-caprolactone) and hydroxyapatite hybrid coatings. J Biomed Mater Res B 70B (2004) 240-249
12. Ignatius A.A., Betz O., Augat P., and Claes L.E. In vivo investigations on composites made of resorbable ceramics and poly(lactide) used as bone graft substitutes. J Biomed Mater Res 58 (2001) 701-709
13. Agrawal C.M., and Athanasiou K.A. Technique to control pH in vicinity of biodegrading PLA-PGA implants. J Biomed Mater Res 38 (1997) 105-114
14. Zhang R., and Ma P.X. Porous poly(l-lactide)/apatite composites created by biomimetic process. J Biomed Mater Res 45 (1999) 285-293
15. Kikuchi M., Koyama Y., Yamada T., Imamura Y., Okada T., Noriaki S., et al. Development of guided bone regeneration membrane composed of β-tricalcium phosphate and poly(l-lactide-co-glycolide-co-ε-caprolactone) composites. Biomaterials 25 (2004) 5979-5986
16. Ara M., Watanabe M., and Imai Y. Effect of blending calcium compounds on hydrolytic degradation of poly(dl-lactide-acid-co-glycolic-acid). Biomaterials 23 (2002) 2479-2483
17. Verma D., Katti K., and Katti D. Bioactivity in in situ hydroxyapatite-polycaprolactone composites. J Biomed Mater Res A 78A (2006) 772-780
18. Kim H.W., Lee E.J., Kim H.E., Salih V., and Knowles J.C. Effect of fluoridation of hydroxyapatite in hydroxyapatite-polycaprolactone composites on osteoblast activity. Biomaterials 26 (2005) 4395
19. Yoo J.J., and Rhee S.H. Evaluations of bioactivity and mechanical properties of poly(ε-caprolactone)/silica nanocomposite following heat treatment. J Biomed Mater Res A 68A (2004) 401-410
20. Lowry K.J., Hamson K.R., Bear L., Peng Y.B., Calaluce R.M., Evans M.L., Anglen J.O., and Allen W.C. Polycaprolactone/glass bioabsorbable implant in a rabbit humerus fracture model. J Biomed Mater Res 36 (1997) 536
21. Lu H.H., El-Amin S.F., Scott K.D., and Laurencin C.T. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro. J Biomed Mater Res A 64A (2003) 465
22. Yao J., Radin S., Leboy P.S., and Ducheyne P. The effect of bioactive glass content on synthesis and bioactivity of composite poly(lactic-co-glycolic acid)/bioactive glass substrate for tissue engineering. Biomaterials 26 (2005) 1935
23. ®-filled polylactide foams for bone tissue engineering scaffolds. J Biomed Mater Res A 67A (2003) 1401
24. Zhang K., Ma Y., and Francis L.F. Porous polymer/bioactive glass composites for soft-to-hard tissue interfaces. J Biomed Mater Res 61 4 (2002) 551-563
25. Korventausta J., Jokinen M., Rosling A., Peltola T., and Yli-Urpo A. Calcium phosphate formation and ion dissolution rates in silica gel-PDLLA composites. Biomaterials 24 (2003) 5173-5182
26. Yao J., Radin S., Reilly G., Leboy P.S., and Ducheyne P. Solution-mediated effect of bioactive glass in poly(lactic-co-glycolic acid)-bioactive glass composites on osteogenesis of marrow stromal cells. J Biomed Mater Res A 75A (2006) 794-801
27. Xynos I.D., Edgar A.J., Buttery L.D., Hench L.L., and Polak J.M. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin like growth factor II mRNA expression and protein syntheses. Biochem Biophys Res Commun 276 (2000) 461-465
28. ® 45S5 dissolution. J Biomed Mater Res 55 (2001) 151-157
29. Hattar S., Loty S., Gaisser D., Berdal A., and Sautier J.M. Effects of 58S sol-gel glasses on the temporal expression of bone markers during mouse osteoblastic differentiation. J Biomed Mater Res A 76A (2006) 811-819
30. Kim H.W., Lee E.J., Jun I.K., Kim H.E., and Knowles J.C. Degradation and drug release of phosphate-glass/polycaprolactone biological composites for hard tissue regenerative. J Biomed Mater Res B 75B (2005) 34-41
31. Kim H.W., Kim H.E., and Knowles J.C. Production and potential of bioactive glass nanofiber as a next generation biomaterial. Adv Fun Mater 16 (2006) 1529-1535
32. Kim H.W., Song J.H., and Kim H.E. Bioactive glass nanofiber-collagen nanocomposite as a novel bone regeneration matrix. J Biomed Mater Res A 79A (2006) 698-705
33. Pitt C.G. Poly ε-caprolactone and its copolymers. In: Langer R., and Chasin M. (Eds). Biodegradable polymers as drug delivery systems (1990), Marcel Dekker, New York 71-120